Daxun Piao

1.1k total citations
25 papers, 783 citations indexed

About

Daxun Piao is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Daxun Piao has authored 25 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Daxun Piao's work include Cancer-related molecular mechanisms research (4 papers), Ubiquitin and proteasome pathways (3 papers) and Cancer Mechanisms and Therapy (2 papers). Daxun Piao is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), Ubiquitin and proteasome pathways (3 papers) and Cancer Mechanisms and Therapy (2 papers). Daxun Piao collaborates with scholars based in China and United States. Daxun Piao's co-authors include Yuekun Zhu, Tao Jiang, Yanwei Xing, Tiemin Zhang, Chengbo Wang, Yayan Bi, Jialan Shi, Junjie Kou, Qingxin Zhou and Liangliang Zhao and has published in prestigious journals such as PLoS ONE, Scientific Reports and Cell Death and Differentiation.

In The Last Decade

Daxun Piao

25 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daxun Piao China 16 482 229 147 142 134 25 783
Xi‐Dai Long China 22 793 1.6× 480 2.1× 102 0.7× 108 0.8× 190 1.4× 65 1.2k
Carolina Armengol Spain 18 486 1.0× 140 0.6× 74 0.5× 172 1.2× 172 1.3× 32 940
Hai-De Qin China 16 403 0.8× 289 1.3× 76 0.5× 132 0.9× 340 2.5× 18 926
Anna Napoli Italy 16 373 0.8× 202 0.9× 131 0.9× 125 0.9× 207 1.5× 44 1.0k
Gabriella Aquino Italy 17 581 1.2× 436 1.9× 105 0.7× 62 0.4× 207 1.5× 44 1000
Christine Payré France 17 411 0.9× 110 0.5× 193 1.3× 193 1.4× 69 0.5× 32 1.1k
Takahide Arimoto Japan 18 349 0.7× 173 0.8× 72 0.5× 274 1.9× 274 2.0× 49 1.0k
Qiurong Ye China 13 401 0.8× 332 1.4× 60 0.4× 157 1.1× 169 1.3× 20 679
Naruhiko Mizuta Japan 15 252 0.5× 169 0.7× 94 0.6× 157 1.1× 106 0.8× 44 683
Xiaoping Geng China 17 320 0.7× 181 0.8× 96 0.7× 99 0.7× 205 1.5× 81 886

Countries citing papers authored by Daxun Piao

Since Specialization
Citations

This map shows the geographic impact of Daxun Piao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daxun Piao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daxun Piao more than expected).

Fields of papers citing papers by Daxun Piao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daxun Piao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daxun Piao. The network helps show where Daxun Piao may publish in the future.

Co-authorship network of co-authors of Daxun Piao

This figure shows the co-authorship network connecting the top 25 collaborators of Daxun Piao. A scholar is included among the top collaborators of Daxun Piao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daxun Piao. Daxun Piao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ren, Shuo, Yanwei Xing, Chengbo Wang, et al.. (2020). Fraxetin inhibits the growth of colon adenocarcinoma cells via the Janus kinase 2/signal transducer and activator of transcription 3 signalling pathway. The International Journal of Biochemistry & Cell Biology. 125. 105777–105777. 16 indexed citations
2.
Jiang, Tao, Chengbo Wang, Yanwei Xing, et al.. (2020). LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis. Aging. 12(11). 11025–11041. 137 indexed citations
3.
Feng, Xing, Yanyan Jia, Yuyu Zhang, et al.. (2019). Ubiquitination of UVRAG by SMURF1 promotes autophagosome maturation and inhibits hepatocellular carcinoma growth. Autophagy. 15(7). 1130–1149. 89 indexed citations
4.
Guan, Rui, et al.. (2018). Identification of critical microRNAs in gastrointestinal stromal tumor patients treated with Imatinib. Neoplasma. 65(5). 683–692. 9 indexed citations
5.
Zhu, Yuekun, Chao Qu, Xuehui Hong, et al.. (2018). Trabid inhibits hepatocellular carcinoma growth and metastasis by cleaving RNF8-induced K63 ubiquitination of Twist1. Cell Death and Differentiation. 26(2). 306–320. 39 indexed citations
6.
Li, Caixia, et al.. (2017). ARID1A gene knockdown promotes neuroblastoma migration and invasion. Neoplasma. 64(3). 367–376. 16 indexed citations
7.
Zhang, Zhenan, Tao Jiang, Wensheng Wang, & Daxun Piao. (2017). Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumor after failure with imatinib and sunitinib treatment. Medicine. 96(48). e8698–e8698. 8 indexed citations
8.
Zhu, Yuekun, Qingxin Zhou, Yanwei Xing, et al.. (2017). GSK-3β phosphorylation-dependent degradation of ZNF281 by β-TrCP2 suppresses colorectal cancer progression. Oncotarget. 8(51). 88599–88612. 13 indexed citations
9.
Chen, Gong, Zhiping Long, Lin Zhu, et al.. (2017). Dietary factors and polymorphisms in vitamin D metabolism genes: the risk and prognosis of colorectal cancer in northeast China. Scientific Reports. 7(1). 8827–8827. 23 indexed citations
10.
Zhao, Zhiwei, et al.. (2017). Downregulated long non‑coding RNA TCONS_00068220 upregulates apoptosis in gastric cancer cells. Oncology Letters. 14(68). 49–52. 4 indexed citations
11.
Zhou, Qingxin, Yuekun Zhu, Xiaoli Wei, et al.. (2016). MiR-590-5p inhibits colorectal cancer angiogenesis and metastasis by regulating nuclear factor 90/vascular endothelial growth factor A axis. Cell Death and Disease. 7(10). e2413–e2413. 68 indexed citations
12.
Zhao, Liangliang, Yayan Bi, Junjie Kou, Jialan Shi, & Daxun Piao. (2016). Phosphatidylserine exposing-platelets and microparticles promote procoagulant activity in colon cancer patients. Journal of Experimental & Clinical Cancer Research. 35(1). 54–54. 71 indexed citations
13.
Ma, Ruishuang, Yan Zhang, Muhua Cao, et al.. (2015). Phosphotidylserine exposure and neutrophil extracellular traps enhance procoagulant activity in patients with inflammatory bowel disease. Thrombosis and Haemostasis. 115(4). 738–751. 83 indexed citations
14.
Zhang, Tiemin, Wei Zhao, Daxun Piao, et al.. (2015). Human cystic echinococcosis in Heilongjiang Province, China: a retrospective study. BMC Gastroenterology. 15(1). 29–29. 22 indexed citations
15.
Zhu, Lin, Yibaina Wang, Jie Ge, et al.. (2014). Association between Toll-like receptor 4 and interleukin 17 gene polymorphisms and colorectal cancer susceptibility in Northeast China. Medical Oncology. 31(10). 73–73. 11 indexed citations
17.
Jiang, Tao, Anlong Zhu, Yuekun Zhu, & Daxun Piao. (2012). Clinical implications of AEG-1 in liver metastasis of colorectal cancer. Medical Oncology. 29(4). 2858–2863. 25 indexed citations
18.
Piao, Daxun, et al.. (2011). Clinical implications of activated leukocyte cell adhesion molecule expression in breast cancer. Molecular Biology Reports. 39(1). 661–668. 26 indexed citations
19.
Piao, Daxun. (2006). Formation of microchimerism in rat small bowel transplantation by splenocyte infusion. World Journal of Gastroenterology. 12(26). 4166–4166. 3 indexed citations
20.
Piao, Daxun. (2003). Continuous regional chemotherapy using arsenic trioxide for primary hepatic carcinoma. Zhonghua gan-dan waike zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026